T1000	Speculation 377 386	predicted
E1000	Speculation:T1000 Scope:T1001
T1001	Span 361 419	which have been predicted to be Asn243, Asn261, and Asn399
T1002	Speculation 328 337	potential
E1001	Speculation:T1002 Scope:T1003
T1003	Span 328 419	potential N-glycosylation sites, which have been predicted to be Asn243, Asn261, and Asn399
T1004	Negation 647 649	no
E1002	Negation:T1004 Scope:T1005
T1005	Span 647 658	no activity
T1006	Negation 616 619	not
E1003	Negation:T1006 Scope:T1007
T1007	Span 606 634	which was not N-glycosylated
T1008	Negation 750 753	not
E1004	Negation:T1008 Scope:T1009
T1009	Span 750 773	not affect its activity
T1010	Negation 700 703	not
E1005	Negation:T1010 Scope:T1011
T1011	Span 660 726	The castanospermine-treated GnT-III was not localized in the Golgi
T1012	Negation 1365 1367	no
E1006	Negation:T1012 Scope:T1013
T1013	Span 1365 1376	no activity
T1014	Speculation 892 901	potential
E1007	Speculation:T1014 Scope:T1015
T1015	Span 892 921	potential glycosylation sites
T1016	Negation 1446 1453	Kinetic
E1008	Negation:T1016 Scope:T1017
T1017	Span 1446 1576	Kinetic analysis revealed that the deglycosylation at Asn243 or Asn261 resulted in slightly lower affinity for the donor substrate
